Kidney dysfunction and fatal cardiovascular disease-an association independent of atherosclerotic events: Results from the Health, Aging, and Body Composition (Health ABC) study

American Heart Journal

Volumn 155, Issue 1, 2008, Pages 62-68

  Deo, Rajat ^a   Wassel Fyr, Christina L ^b   Fried, Linda F ^c,d   Newman, Anne B ^c,e   Harris, Tamara B ^f   Angleman, Sara ^f   Green, Christie ^g   Kritchevsky, Stephen B ^h   Chertow, Glenn M ^b   Cummings, Steven R ⁱ   Shlipak, Michael G ^j  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^f Demography and Biometry   (United States)

^g UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^h WAKE FOREST SCHOOL OF MEDICINE   (United States)

ⁱ CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^j SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYSTATIN C;

AGED; AGING; ARTICLE; ATHEROSCLEROSIS; BODY COMPOSITION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FATALITY; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH STATUS; HEART DEATH; HEART INFARCTION; HUMAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; STROKE;

AGE DISTRIBUTION; AGED; AGING; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BODY COMPOSITION; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COHORT STUDIES; COMORBIDITY; CONFIDENCE INTERVALS; CREATININE; CYSTATINS; FEMALE; GLOMERULAR FILTRATION RATE; HEALTH STATUS; HEALTH SURVEYS; HUMANS; INCIDENCE; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SEX DISTRIBUTION; SURVIVAL ANALYSIS;

EID: 36849019153     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.08.012     Document Type: Article

References (17)

1. Fried L.P., Kronmal R.A., Newman A.B., et al. Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study. JAMA 279 (1998) 585-592
2. Go A.S., Chertow G.M., Fan D., et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351 (2004) 1296-1305
3. Kassirer J.P. Clinical evaluation of kidney function-tubular function. N Engl J Med 285 (1971) 499-502
4. Kassirer J.P. Clinical evaluation of kidney function-glomerular function. N Engl J Med 285 (1971) 385-389
5. Coll E., Botey A., Alvarez L., et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis 36 (2000) 29-34
6. Dharnidharka V.R., Kwon C., and Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 40 (2002) 221-226
7. Erlandsen E.J., Randers E., and Kristensen J.H. Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System. Scand J Clin Lab Invest 59 (1999) 1-8
8. Levey A.S., Bosch J.P., Lewis J.B., et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
9. Shlipak M.G., Fyr C.L., Chertow G.M., et al. Cystatin C and mortality risk in the elderly: the Health, Aging, and Body Composition study. J Am Soc Nephrol 17 (2006) 254-261
10. Shlipak M.G., Sarnak M.J., Katz R., et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 352 (2005) 2049-2060
11. Levey A.S., Coresh J., Balk E., et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139 (2003) 137-147
12. Fried L.F., Shlipak M.G., Crump C., et al. Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. J Am Coll Cardiol 41 (2003) 1364-1372
13. Shlipak M.G., Fried L.F., Crump C., et al. Cardiovascular disease risk status in elderly persons with renal insufficiency. Kidney Int 62 (2002) 997-1004
14. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
15. Tonelli M., Wiebe N., Culleton B., et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 17 (2006) 2034-2047
16. Koenig W., Twardella D., Brenner H., et al. Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate. Clin Chem 51 (2005) 321-327
17. Jernberg T., Lindahl B., James S., et al. Cystatin C: a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome. Circulation 110 (2004) 2342-2348